ADM and hepatocellular carcinoma: Furthermore, Transwell invasion assays performed in Huh7 cells showed fewer cells in the sh-ADM group traversed the chamber relative to the sh-NC group, establishing that ADM downregulation attenuates hepatocellular carcinoma cell invasive capacity (Figure 5E).